A Randomized Crossover Study Comparing Patient Preference for Tamsulosin and Silodosin in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

By Watanabe T   Ozono S   Kageyama S  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 129-142

Field House Publishing

Access to resources Recommend Favorite

Silodosin, a novel selective α_1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia

By Yoshida Masaki   Homma Yukio   Kawabe Kazuki  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1955-1965

Informa Healthcare

Access to resources Recommend Favorite

Alfuzosin: an α₁-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

By Elhilali Mostafa M  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 583-596

Informa Healthcare

Access to resources Recommend Favorite

Silodosin: Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia

By Curran Monique P.  

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 897-907

Adis International

Access to resources Recommend Favorite

Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Djavan Bob   Handl Markus Johannes   Dianat Saeid  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2535-2547

Informa Healthcare

Access to resources Recommend Favorite